Firms

Norwest Venture Partners

signal.nfx.com

A multi-stage venture and growth equity investment firm backing companies across enterprise, consumer and healthcare sectors.

Founded: —
Type: Venture capital

Funds6

NVP XVII2024-04-252024-04-25$3B
Closed global flagship USD3B. USD15.5B total capital under management is firm-wide, not fund size or remaining capital.
NVP XVI2021-122021-12$3B
Historical predecessor raised December2021, USD3B; precise announcement day not established here.
Norwest Venture Partners XV2019-11-142019-11-14$2B
Official close announcement for USD 2 billion Fund XV.
Norwest Venture Partners XIV2018-02-142018-02-14$1.5B
Official close announcement for USD 1.5 billion Fund XIV.
Norwest Venture Partners XIII2016-01-202016-01-20$1.2B
Official formation and close announcement for USD 1.2 billion Fund XIII.
Norwest Venture Partners XII—$1.2B
Official Fund XIII announcement confirms USD 1.2 billion predecessor Fund XII.

Team

Paul Kigawa Norwest Venture Partners, investor	$50M$25M – $75M	New York, New York
Christopher Scullin Norwest Venture Partners, partner	$15M$5M – $25M	Boston, Massachusetts
Yoni Braun Norwest Venture Partners, vice_president	$12M$1M – $30M	Israel
Sonya Brown Norwest Venture Partners, general_partner	$12M$1M – $30M	Menlo Park, California
David Su Norwest Venture Partners, partner	$12M$1M – $30M	Palo Alto, California
Dror Nahumi Norwest Venture Partners, general_partner	$12M$1M – $30M	Palo Alto, California
Jeff Crowe Norwest Venture Partners, managing_partner	$12M$1M – $30M	Palo Alto, California
Jon Kossow Norwest Venture Partners, managing_partner	$12M$1M – $30M	Palo Alto, California
Laura Boyd Norwest Venture Partners, principal	$12M$1M – $30M	Palo Alto, California
Matthew Howard Norwest Venture Partners, managing_partner	$12M$1M – $30M	Palo Alto, California
Promod Haque Norwest Venture Partners, venture_partner	$12M$1M – $30M	Palo Alto, California
Rama Sekhar Norwest Venture Partners, partner	$12M$1M – $30M	Palo Alto, California
Robert Abbott Norwest Venture Partners, partner	$12M$1M – $30M	Palo Alto, California
Scott Mitchell Norwest Venture Partners, partner	$12M$1M – $30M	Palo Alto, California
Stew Campbell Norwest Venture Partners, partner	$12M$1M – $30M	Palo Alto, California
Brian Matesic Norwest Venture Partners, principal	$12M$1M – $30M	San Francisco Bay Area
Brian Moon Norwest Venture Partners, investor	$12M$1M – $30M	San Francisco Bay Area
Jessica Yi Norwest Venture Partners, vice_president	$12M$1M – $30M	San Francisco Bay Area
Lisa Ames Norwest Venture Partners, principal	$12M$1M – $30M	San Francisco Bay Area
Lisa Wu Norwest Venture Partners, partner	$12M$1M – $30M	San Francisco Bay Area
Parker Barrile Norwest Venture Partners, partner	$12M$1M – $30M	San Francisco Bay Area
Ran Ding Norwest Venture Partners, vice_president	$12M$1M – $30M	San Francisco Bay Area
Sanchana Vasikaran Norwest Venture Partners, investor	$12M$1M – $30M	San Francisco Bay Area
Stephen Xi Norwest Venture Partners, investor	$12M$1M – $30M	San Francisco Bay Area
Casper de Clercq Norwest Venture Partners, general_partner	$12M$1M – $30M	San Francisco, California
Chris Sondej Norwest Venture Partners, vice_president	$12M$1M – $30M	San Francisco, California
Connor Pike Norwest Venture Partners, vice_president	$12M$1M – $30M	San Francisco, California
David Zilberman Norwest Venture Partners, general_partner	$12M$1M – $30M	San Francisco, California
Edward Yip Norwest Venture Partners, partner	$12M$1M – $30M	San Francisco, California
Jordan Leites Norwest Venture Partners, principal	$12M$1M – $30M	San Francisco, California
Priti Youssef Choksi Norwest Venture Partners, partner	$12M$1M – $30M	San Francisco, California
Ryan Harris Norwest Venture Partners, general_partner	$12M$1M – $30M	San Francisco, California
Scott Beechuk Norwest Venture Partners, partner	$12M$1M – $30M	San Francisco, California
Trey Jennings Norwest Venture Partners, senior_associate	$12M$1M – $30M	San Francisco, California
Sean Jacobsohn Norwest Venture Partners, partner	$10M$5M – $30M	San Francisco Bay Area
Zack Scott Norwest Venture Partners, general_partner	$1M$100K – $5M	San Francisco, California
Sergio Monsalve Norwest Venture Partners, partner	$1M$500K – $2M	San Francisco Bay Area
Venkat Mohan Norwest Venture Partners, partner	$25K$10K – $50K	San Francisco Bay Area
Josh Goldman Norwest Venture Partners, partner	$25K$10K – $50K	Saratoga, California
Jared Hyatt Norwest Venture Partners, investor	$0$0 – $0	Palo Alto, California

Investments

$28M2026-06-24	Coval	Y Combinator, Twilio Ventures, Pioneer Fund, Base10 Partners, Norwest Venture Partners
$14M2026-02-20	InScope	Lightspeed, Story Ventures, Norwest Venture Partners, Better Tomorrow Ventures
$250M2026-01-09	Rain	Lightspeed, Galaxy Ventures, FirstMark Capital, Norwest Venture Partners, Dragonfly, Galaxy Digital Ventures
$130M2025	Apreo Health	Bain Capital, F-Prime Capital, Xfund, Lightstone Ventures, Norwest Venture Partners, Intuitive Ventures
$125M2023-12-20	Vestwell	Lightspeed, Blue Owl Capital, FinTech Collective, Primary Venture Partners, Fin Capital, Norwest Venture Partners
$120M2023-11-07	Enable	Lightspeed, Sierra Ventures, Menlo Ventures, Insight Partners, Norwest Venture Partners, Sean Jacobsohn, Tim Guleri
$50M2023-05-16	Spiff	Lightspeed, Album VC, Salesforce Ventures, Norwest Venture Partners, Kickstart Ventures, Sean Jacobsohn
$80M2023-01-19	SetPoint Medical	Norwest Venture Partners, Zack Scott
$16M2023	VenoStent	Y Combinator, Good Growth Capital, Norwest Venture Partners, IAG Capital Partners
$48M2022-12-15	BillionToOne	Hummingbird Ventures, Norwest Venture Partners
$15M2022-10-04	Xembly	Lightspeed, Flex Capital, Ascend, Norwest Venture Partners, Seven Peaks Ventures, Priti Youssef Choksi
$75M2022-03-31	Citymall	General Catalyst, Norwest Venture Partners, Jungle Ventures
$160M2022-01-25	Dremio	Lightspeed, Adams Street Partners, Insight Partners, Norwest Venture Partners, Sapphire Ventures, Cisco Investments, Rama Sekhar
$200M2021-06-02	Exabeam	Lightspeed, Blue Owl Capital, Acrew Capital, Norwest Venture Partners
$55M2021-06-01	BillionToOne	Y Combinator, NeoTribe Ventures, Four Rivers Group, Hummingbird Ventures, Norwest Venture Partners, Libertus Capital
$155M2021-05-04	Honeybook, Inc.	Durable Capital Partners, Tiger Global Management, Battery Ventures, Zeev Ventures, 01 Advisors, Norwest Venture Partners, Citi Ventures
$—2021	Forum	Y Combinator, NFX, Norwest Venture Partners
$46M2021	Spiff	Lightspeed, Stripes, Salesforce Ventures, Norwest Venture Partners
$30M2020-10-26	Celona	Lightspeed, Qualcomm Ventures, NTTVC, Norwest Venture Partners, Cervin
$42M2020-03-16	Proxy	Y Combinator, Kleiner Perkins, Silicon Valley Bank, WestCap, Scale Venture Partners, Norwest Venture Partners
$10M2020	Spiff	Lightspeed, Norwest Venture Partners
$65M2019-12-03	Gong	Sequoia, Battery Ventures, XYZ Venture Capital, Wing Venture Capital, Norwest Venture Partners, NextWorld Capital, Peter Wagner, Dror Nahumi
$50M2019-05-29	Talkspace	Compound, Soma Capital, Revolution Growth, Spark Capital, Norwest Venture Partners, Qumra Capital, Jeff Crowe
$100M2019-02-07	Health Catalyst	Sequoia, OrbiMed, Kaiser Permanente Ventures, Sands Capital, UPMC Enterprises, Norwest Venture Partners
$25M2019-02-05	Ritual	Founders Fund, Forerunner Ventures, Norwest Venture Partners, Lisa Wu
$25M2019	Ritual	Founders Fund, Insight Partners, Forerunner Ventures, Norwest Venture Partners
$30M2018-09-18	Singular	General Catalyst, Norwest Venture Partners, Thomvest Ventures, Translink Capital, Titanium Ventures, Method Capital
$46M2018-02-28	Mist Systems Inc.	Lightspeed, Kleiner Perkins, Norwest Venture Partners, NTT DOCOMO Ventures, Dimension Data
$46M2018-02-28	Mist Systems	Lightspeed, Kleiner Perkins, GV, Norwest Venture Partners, NTT DATA, NTT DOCOMO Ventures
$31M2017-09-07	Talkspace	Compound, SoftBank Vision Fund, Spark Capital, Norwest Venture Partners, Qumra Capital
$10M2017-08-01	Ritual	Founders Fund, Upfront Ventures, Forerunner Ventures, Norwest Venture Partners
$10M2017-08	Ritual	Founders Fund, Upfront Ventures, Insight Partners, Forerunner Ventures, Norwest Venture Partners
$14M2017-03-21	Avere Systems	Menlo Ventures, Norwest Venture Partners, Lightspeed Venture Partners, Tenaya Capital, Western Digital Capital, Google, Matthew Howard
$15M2016-06-14	Talkspace	Compound, Spark Capital, Norwest Venture Partners, Jeff Crowe
$20M2016-01-26	Fireglass	Lightspeed, Singtel Innov8, Norwest Venture Partners, Digital Transformation Capital Partners
$45M2015-09-02	Capillary Technologies	Sequoia, Norwest Venture Partners, Warburg Pincus LLC
$14M2014-07-17	Capillary Technologies	Sequoia, India Quotient, Norwest Venture Partners
$10M2012-10-11	Pontis	Sequoia, Qualcomm Ventures, Accel, Norwest Venture Partners, Evergreen Venture Partners, Dror Nahumi
$15M2012-09-25	Capillary Technologies	Sequoia, Qualcomm Ventures, Norwest Venture Partners
$20M2012-07-10	Avere Systems	Matthew Howard, Norwest Venture Partners
$70M2012-04-17	Skybox Imaging	Norwest Venture Partners, Khosla Ventures, Canaan Partners, Bessemer Venture Partners, Promod Haque
$43M2009-11-11	Playdom	Lightspeed, New Enterprise Associates, Norwest Venture Partners, Bessemer Venture Partners, Inbox Capital, Steamboat Ventures
$196M2007-12-20	Kayak	General Catalyst, Silicon Valley Bank, Accel, Oak Investment Partners, Norwest Venture Partners, Sequoia, Trident Capital
$1MUnknown date	Goodly	Y Combinator, Norwest Venture Partners, ACE & Company
$1MUnknown date	College Pulse	Y Combinator, Norwest Venture Partners, Madrona Venture Group
$140MUnknown date	Fabric Health	Y Combinator, Stripes, Forerunner Ventures, Redpoint Ventures, Glynn Capital, Norwest Venture Partners
$32MUnknown date	Telcare	Sequoia, Qualcomm Ventures, Norwest Venture Partners, Deutsche Telekom
$250MUnknown date	Honeybook, Inc.	OurCrowd, Durable Capital Partners, Battery Ventures, Citi Ventures, Tiger Global Management, LLC, Norwest Venture Partners
$25MUnknown date	SnapRoute	Lightspeed, Western Technology Investment, Norwest Venture Partners
$—Unknown date	Avere Systems	Lightspeed, Western Digital, Menlo Ventures, Tenaya Capital, Norwest Venture Partners
$20MUnknown date	Qubole	Lightspeed, Norwest Venture Partners
$2MUnknown date	The Breakaway	General Catalyst, Y Combinator, Norwest Venture Partners
$10MUnknown date	Ritual	Founders Fund, Forerunner Ventures, Upfront Ventures, Insight Partners, Norwest Venture Partners
$130MUnknown date	Apreo Health	Bain Capital, F-Prime Capital, Fidelity Investments, Lightstone Ventures, Norwest Venture Partners, Intuitive Ventures
$130M2025	Apreo	Bain Capital, F-Prime Capital, Lightstone Ventures, Norwest Venture Partners, Intuitive Ventures
$66M2024-10-09	ShiraTronics	Norwest Venture Partners, Zack Scott
$157M2024-03-19	Engrail Therapeutics	Norwest Venture Partners
$10M2017-08-01	Ritual Vitamins	Founders Fund, Forerunner Ventures, Upfront Ventures, Norwest Venture Partners
$5M2013-07-08	Seculert	Sequoia, Norwest Venture Partners, YL Ventures
$20M2013	Pertino	Lightspeed, Icon Ventures, Norwest Venture Partners, JAFCO Group Co., Ltd.
$8M2003	Cast Iron Systems	Sequoia, Tenaya Capital, Norwest Venture Partners
$20MUnknown date	Pertino	Lightspeed, Icon Ventures, Norwest Venture Partners, JAFCO Group Co., Ltd.

team@apexlogos.ai2 hours ago
Investment-fund research reviewed 2026-10-06. Publicly identified funds, dates, amounts and fundraising status are below. Undisclosed commitments remain unknown; this is not a complete register of private SPVs or parallel entities. Funds, capital and stages | Item | Amount / status | Evidence and date | |---|---|---| | NVP XVII, LP / NVP 17 | **USD 3 billion, closed**, global flagship | [Official announcement](https://www.norwest.com/news/norwest-3-billion-global-fund-next-generation-enduring-companies/), 2024-04-25. Latest-known announced flagship found; targeted searches for NVP XVIII / 18 and 2025–2026 closes did not establish a newer fund. | | NVP XVI / NVP 16 | USD 3 billion predecessor; raised December 2021 | Same 2024 announcement identifies the predecessor and fundraising timing. | | Total capital under management | USD 15.5 billion following NVP 17 | Same announcement; this aggregate is **not** the size of NVP 17 or deployable capital remaining. The [India strategy page](https://www.norwest.com/india/) repeats USD 15.5B and says India participates in the global flagship funds (undated). | The [current venture strategy page](https://www.norwest.com/venture/) (undated) explicitly supports **early- through late-stage venture** and **USD 1M–30M equity checks**. This is an official venture practice range, not a universal range for all Norwest growth equity or healthcare transactions. Norwest also invests growth equity; the fund announcement supports a multi-sector and multi-stage mandate, principally North America, India and Israel. The India page separately specifies early/mid-stage venture USD 10M–30M and late-stage/growth USD 20M–100M. Historical round examples below illustrate execution but do not by themselves establish the current mandate. No verified firm-wide sweet spot or dedicated neurotech fund was found. Additional verified fund-history sources checked in this review: - Norwest Venture Partners XII: USD 1200000000. Official Fund XIII announcement confirms USD 1.2 billion predecessor Fund XII. [Source](https://www.norwest.com/blog/nvp-raises-new-1-2b-fund-to-support-its-growing-network-of-portfolio-companies/). - Norwest Venture Partners XIII: USD 1200000000. Official formation and close announcement for USD 1.2 billion Fund XIII. [Source](https://www.norwest.com/blog/nvp-raises-new-1-2b-fund-to-support-its-growing-network-of-portfolio-companies/). - Norwest Venture Partners XIV: USD 1500000000. Official close announcement for USD 1.5 billion Fund XIV. [Source](https://www.norwest.com/blog/introducing-nvp-xiv-largest-fund-date-will-help-us-support-tomorrows-big-ideas/). - Norwest Venture Partners XV: USD 2000000000. Official close announcement for USD 2 billion Fund XV. [Source](https://www.norwest.com/blog/announcing-nvp-xv-our-new-2b-fund/). - Norwest Venture Partners XVI: USD 3000000000. Official Fund XVII announcement confirms USD 3 billion predecessor Fund XVI. [Source](https://www.norwest.com/news/norwest-3-billion-global-fund-next-generation-enduring-companies/). - Norwest Venture Partners XVII: USD 3000000000. Official close announcement for USD 3 billion Fund XVII. [Source](https://www.norwest.com/news/norwest-3-billion-global-fund-next-generation-enduring-companies/). Funds recorded in Adex after this review: | Fund | Disclosed amount | Announcement / filing date | | --- | --- | --- | | Norwest Venture Partners XII | USD 1200000000 | Unknown | | Norwest Venture Partners XIII | USD 1200000000 | 2016-01-20 | | Norwest Venture Partners XIV | USD 1500000000 | 2018-02-14 | | Norwest Venture Partners XV | USD 2000000000 | 2019-11-14 | | NVP XVI | USD 3000000000 | 2021-12 | | NVP XVII | USD 3000000000 | 2024-04-25 |
team@apexlogos.ai3 hours ago
Match research 2026-10-06 / NorwestVenturePartners / sha256:4eaab56558baffa9367c59dc51aa1dd917db31b2d8a3d325c4da48091d541781 / part 2 of 2 Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats. | **ShiraTronics — direct neurostimulation** | Implantable neuromodulation system delivers electrical pulses to occipital and supraorbital nerves associated with migraine pain. This is direct neural stimulation, not a mental-health service or generic software product. | **USD 66M Series B led by new investor Norwest**, announced **2024-10-09**. [Official company news page](https://shiratronics.com/news/) and [company-issued release](https://www.prnewswire.com/apac/news-releases/shiratronics-raises-66-million-in-oversubscribed-series-b-financing-to-advance-pioneering-treatment-for-chronic-migraine-302270958.html). [Fierce Biotech reporting](https://www.fiercebiotech.com/medtech/shiratronics-raises-66m-its-neuromodulation-implant-chronic-migraines), 2024-10-09, independently supports the round and nerve targets. | SetPoint has later financing evidence: [MassDevice](https://www.massdevice.com/setpoint-medical-140m-neuromod-commercialization/), **2025-08-11**, reports USD 140M private financing comprising a second Series C tranche and Series D, with Norwest returning. [MedTech Dive](https://www.medtechdive.com/news/SetPoint-Medical-140M-financing-arthritis-vagus-nerve-neuromodulation/757338/), same date, splits this into USD 25M plus USD 115M. Do not assume USD 140M is one new standalone Series D or Norwest's check. The 2023 technology description is historical; no current clinical or regulatory status conclusion is made here. **Adjacent holdings:** Engrail's neuroscience drug pipeline is verified above but is kept distinct from direct stimulation, sensing or brain-computer interface technology. Talkspace appears in Adex's 2016/2017/2019 round records; teletherapy/mental-health care alone does not qualify as direct neurotechnology, and those funding entries were not independently reverified in this focused review. Norwest's official 2024 fund announcement names Ray Therapeutics as a healthcare investment, but a transaction-specific technology/attribution review was not completed and it is not promoted into the verified neurotech list. ## Conflicts, missing information and later Adex review - Strong additions for later review are NVP 17's **closed USD 3B** with its date, the distinct USD 15.5B capital-under-management claim, current official venture stages/check range, and directly sourced SetPoint and ShiraTronics investments. No update is authorized by this research task. - Prefer SetPoint's company release's **co-led with Viking** to wording in Norwest's blog that it “led” the financing. Preserve preferred-stock financing terminology; aggregators disagree on alphabetic series labels for the 2023 round, so no series label is assigned here. - ShiraTronics aggregators sometimes date the same Series B to 2024-09-30; use **2024-10-09 as public announcement date**, not an inferred legal closing date. - Eonite Perception remains unverified for Norwest; databases inspected named other investors. Do not infer participation from the baseline disjunctive statement. Avere attribution is independently confirmed. - Norwest's actual per-company contribution amounts, remaining fund capacity and a universal sweet spot remain undisclosed in the sources checked. Check-size ranges vary by geography and practice; avoid flattening India/growth ranges into the venture range. - Snapshot duplicates and undated roles need entity/team review before any import; partner histories at earlier firms should not be attributed to Norwest. This file verifies selected technical/neurotech examples, not the full 700-plus company historical portfolio or every baseline transaction. - No newer flagship fund was established through the targeted current-date search. “Latest-known” is intentional; absence from search is not proof that no newer close exists. All linked sources were accessed 2026-10-06. Undated strategy/profile pages are current observed claims; dated releases establish historical transactions. Company and investor releases are primary attribution evidence but may contain promotional technical claims. Technical classifications here are explicit analytical judgments.
team@apexlogos.ai3 hours ago
Match research 2026-10-06 / NorwestVenturePartners / sha256:4eaab56558baffa9367c59dc51aa1dd917db31b2d8a3d325c4da48091d541781 / part 1 of 2 Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats. # Norwest Venture Partners - Exact Adex ID: `NorwestVenturePartners` - Canonical Adex URL: https://adex.page/firms/NorwestVenturePartners - Official website: https://www.norwest.com/ - Research date / all source access dates: 2026-10-06 - Status: complete research for later Adex review; no database changes made. Norwest is a diversified venture and growth equity investor with verified technical investments spanning satellite hardware, advanced storage and molecular diagnostics. **Direct neurotechnology investments are verified in SetPoint Medical and ShiraTronics**, both implantable nerve-stimulation companies. Neuroscience therapeutics exposure through Engrail is separately classified below. ## Starting evidence and identity The saved exact-ID snapshot, `data/research/_sources/NorwestVenturePartners.adex.json` (retrieved 2026-10-06), describes a multi-stage investor across enterprise, consumer and healthcare. Its firm check minimum, maximum and sweet spot are null. It contains many Goldi-derived participations, including Avere Systems, Skybox Imaging, BillionToOne, Celona and Talkspace, plus duplicates such as Apreo/Apreo Health and several Ritual and Mist records. These are baseline claims, not independent confirmation. The baseline hardware evidence says “Avere Systems or Eonite Perception”; Avere was verified, while Eonite attribution was not established. [NFX Signal firm profile](https://signal.nfx.com/firms/norwest-venture-partners) was directly accessible as text in the initial read and also search-index accessible; a later read returned only a short shell. Initial content associates investor profiles with seed, Series A and Series B, and semiconductor/AI/IoT interests. Several investors show USD 1M–30M ranges and USD 12.5M sweet spots; other profiles vary materially. These are person-level, potentially stale directory claims, not independently verified firm parameters. Signal's roster and title assertions should not replace a current official team review. The official firm, not similarly named Norwest Equity Partners or Australian Norwest businesses, is the subject here. ## Funds, capital and stages | Item | Amount / status | Evidence and date | |---|---|---| | NVP XVII, LP / NVP 17 | **USD 3 billion, closed**, global flagship | [Official announcement](https://www.norwest.com/news/norwest-3-billion-global-fund-next-generation-enduring-companies/), 2024-04-25. Latest-known announced flagship found; targeted searches for NVP XVIII / 18 and 2025–2026 closes did not establish a newer fund. | | NVP XVI / NVP 16 | USD 3 billion predecessor; raised December 2021 | Same 2024 announcement identifies the predecessor and fundraising timing. | | Total capital under management | USD 15.5 billion following NVP 17 | Same announcement; this aggregate is **not** the size of NVP 17 or deployable capital remaining. The [India strategy page](https://www.norwest.com/india/) repeats USD 15.5B and says India participates in the global flagship funds (undated). | The [current venture strategy page](https://www.norwest.com/venture/) (undated) explicitly supports **early- through late-stage venture** and **USD 1M–30M equity checks**. This is an official venture practice range, not a universal range for all Norwest growth equity or healthcare transactions. Norwest also invests growth equity; the fund announcement supports a multi-sector and multi-stage mandate, principally North America, India and Israel. The India page separately specifies early/mid-stage venture USD 10M–30M and late-stage/growth USD 20M–100M. Historical round examples below illustrate execution but do not by themselves establish the current mandate. No verified firm-wide sweet spot or dedicated neurotech fund was found. ## Named previous deep-tech investments Round amounts below are total syndicate financings, not Norwest's individual check. Classification is a research judgment based on the technology described, rather than a firm sector label. | Company | Technology rationale | Firm attribution / supported financing | Sources and dates | |---|---|---|---| | **Skybox Imaging** | Designed and launched high-resolution imaging microsatellites; substantive space hardware and remote-sensing engineering. | USD 70M Series C co-led by Canaan Partners and Norwest; development/launch capital for SkySat-1 and SkySat-2. | [Skybox company release republished by SpaceRef](https://spaceref.com/space-commerce/skybox-imaging-raises-70-million-in-new-financing-2/), 2012-04-18. Adex says 2012-04-17; treat the linked publication date separately from announcement/closing date. | | **Avere Systems** | Network-attached storage architecture integrating flash, virtualization and cloud through FXT edge filers; advanced infrastructure/appliance engineering. | Norwest named as an existing investor participating in USD 20M Series C, led by Lightspeed. | [Avere-issued release](https://www.prnewswire.com/news-releases/investors-back-avere-with-additional-20-million-161927795.html), 2012-07-10. This verifies the firm directly without relying on the ambiguous baseline “Avere or Eonite” claim. | | **BillionToOne** | Proprietary molecular counting platform for diagnostics, including single-molecule DNA quantification; biotech/diagnostic deep tech, not neurotechnology. | Company names Norwest among participating existing Series C investors in an additional USD 48.5M equity raise. A separate term-loan facility was upsized to USD 35M; do not combine this into an equity round. | [Company release](https://www.billiontoone.com/news-media/billiontoone-announces-48-5m-additional-capital-raise-and-35m-upsized-term-loan-facility-demonstrating-investor-and-lender-confidence-in-the-companys-rapid-growth), dateline 2022-12-15 / page date 2022-12-16; [official investor description](https://investors.billiontoone.com/), undated. The saved 2021 USD 55M round was a lead but its exact Norwest participation/date was not the basis of this verification. | | **Engrail Therapeutics** | Precision neuroscience drug development for neuropsychiatric and neurodevelopmental disorders; scientific biotech investment, separately marked neuroscience-adjacent. | USD 157M Series B co-led by new investors F-Prime, Forbion and Norwest. Norwest is specifically named, rather than inferred from an individual's previous employer. | [Co-investor Forbion-hosted company release](https://forbion.com/media/hjrfryn0/1677-forbion-co-leads-oversubscribed-157m-series-b-financing-round-in.pdf), 2024-03-19. [Company-issued syndicated release](https://en.prnasia.com/releases/apac/engrail-therapeutics-closes-oversubscribed-157m-series-b-financing-round-to-advance-the-development-of-transformational-therapies-440387.shtml), 2024-03-20, confirms the financing. | SetPoint and ShiraTronics below also qualify as engineering-intensive medical-device deep tech. Ordinary enterprise SaaS holdings in the snapshot are not automatically categorized as deep tech. ## Named previous neurotech investments | Company / classification | Neural technology and attribution | Financing evidence | |---|---|---| | **SetPoint Medical — direct peripheral neurotechnology / bioelectronic medicine** | Miniaturized implant placed on the vagus nerve, programmed electrical stimulation to engage the inflammatory reflex. It targets autoimmune disease; the nervous-system interface makes it direct neurotechnology even though its first indication is rheumatoid arthritis, rather than a brain disorder. | [Company announcement](https://setpointmedical.com/setpoint-medical-announces-80m-preferred-stock-financing-to-advance-companys-novel-treatment-for-autoimmune-diseases/), **2023-01-19**, identifies **USD 80M preferred-stock financing co-led by new investors Norwest and Viking Global**. Zack Scott joined the board. The separate up-to-USD 65M debt facility is not Norwest equity. [Norwest investment article](https://www.norwest.com/blog/setpoint-medical-targeting-breakthroughs-in-the-treatment-of-autoimmune-diseases/), same date, corroborates investment and device rationale. |
team@apexlogos.ai22 days ago
MATCH

Funds6

Team

Co-investing

Investments